Masanari Hamaguchi

423 total citations
19 papers, 139 citations indexed

About

Masanari Hamaguchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Masanari Hamaguchi has authored 19 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Masanari Hamaguchi's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Masanari Hamaguchi is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Masanari Hamaguchi collaborates with scholars based in Japan, United Kingdom and United States. Masanari Hamaguchi's co-authors include Takayuki Shiroyama, Hiroshi Kida, Izumi Nagatomo, Taro Koba, Takashi Kijima, Motohiro Tamiya, Tomonori Hirashima, Atsushi Kumanogoh, Hidekazu Suzuki and Yoshito Takeda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Medicine.

In The Last Decade

Masanari Hamaguchi

18 papers receiving 138 citations

Peers

Masanari Hamaguchi
Stephan Spahn Germany
Kimberly Tang United States
Dimitrios Korentzelos United States
Nicholas Venturini United States
Daphne N. Pariser United States
Elisabetta Casalone Italy
Yasuhide Takeuchi Japan
Marcelo Luiz Balancin Brazil
Marc Cucurull Spain
Diane Evrard France
Stephan Spahn Germany
Masanari Hamaguchi
Citations per year, relative to Masanari Hamaguchi Masanari Hamaguchi (= 1×) peers Stephan Spahn

Countries citing papers authored by Masanari Hamaguchi

Since Specialization
Citations

This map shows the geographic impact of Masanari Hamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanari Hamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanari Hamaguchi more than expected).

Fields of papers citing papers by Masanari Hamaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanari Hamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanari Hamaguchi. The network helps show where Masanari Hamaguchi may publish in the future.

Co-authorship network of co-authors of Masanari Hamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masanari Hamaguchi. A scholar is included among the top collaborators of Masanari Hamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanari Hamaguchi. Masanari Hamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Otsuka, Tomoyuki, Sumiyuki Nishida, Burcu Temizoz, et al.. (2022). CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study. BMC Cancer. 22(1). 744–744. 18 indexed citations
3.
Takimoto, Takayuki, Futoshi Nakagami, Masanari Hamaguchi, et al.. (2019). A lung abscess caused by secondary syphilis – the utility of polymerase chain reaction techniques in transbronchial biopsy: a case report. BMC Infectious Diseases. 19(1). 598–598. 8 indexed citations
4.
Nozaki, Kenji, Sachiko Ezoe, Masanari Hamaguchi, et al.. (2019). Unexpected Complication of R-CHOP Chemotherapy: Rapidly Progressive Bronchiolitis Obliterans Syndrome. SHILAP Revista de lepidopterología. 6(11). 1–1.
5.
Otsuka, Tomoyuki, Sumiyuki Nishida, Masanari Hamaguchi, et al.. (2019). Phase I study of CpG ODN(K3), a novel toll-like receptor 9 agonist, for advanced lung cancer: Interim analyses of safety and immunity in subcutaneous injection cohort.. Journal of Clinical Oncology. 37(8_suppl). 126–126. 2 indexed citations
6.
Koba, Taro, Haruhiko Hirata, Takashi Kijima, et al.. (2018). [A Case of Mediastinal Small Cell Lung Cancer in a Patient Receiving Mechanical Ventilation Who Was Successfully Treated with Chemotherapy and Finally Extubated].. PubMed. 45(9). 1335–1337. 1 indexed citations
7.
Koba, Taro, Takashi Kijima, Takayuki Takimoto, et al.. (2017). Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation. Medicine. 96(6). e6087–e6087. 19 indexed citations
8.
Naito, Yujiro, Akihiro Tamiya, Motohiro Tamiya, et al.. (2017). Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer. Medicine. 96(35). e7884–e7884. 14 indexed citations
9.
Kondo, Yoko, Hidekazu Suzuki, Norio Okamoto, et al.. (2016). Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash. European Journal of Hospital Pharmacy. 24(5). 283–285. 1 indexed citations
10.
Tamiya, Motohiro, Akihiro Tamiya, Keiko Nakao, et al.. (2016). Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.. PubMed. 36(6). 2939–44. 17 indexed citations
11.
Shiroyama, Takayuki, Norio Okamoto, Motohiro Tamiya, et al.. (2016). Effective Management of Persistent Pneumothorax Using a Thopaz<sup>&reg;</sup> Digital Drainage System Combined with an Endobronchial Watanabe Spigot. Internal Medicine. 55(6). 663–665. 3 indexed citations
12.
Iwata, Kaori, Hidekazu Suzuki, Motohiro Tamiya, et al.. (2015). [Retrospective Analysis of the Afatinib Clinical Pathway during the 28-Day Introductory Period-The Japanese Style of Collaborative Drug Therapy Management(J-CDTM)].. PubMed. 42(8). 967–72. 4 indexed citations
13.
Okamoto, Norio, Hidekazu Suzuki, Kunimitsu Kawahara, et al.. (2015). The alternatively spliced actinin-4 variant as a prognostic marker for metastasis in small-cell lung cancer.. PubMed. 35(3). 1663–7. 10 indexed citations
14.
Shiroyama, Takayuki, Ayako Tanaka, Motohiro Tamiya, et al.. (2015). A Rare Case of Pleomorphic Carcinoma of the Lung Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement. Internal Medicine. 54(21). 2741–2743. 3 indexed citations
15.
Minami, Seigo, Suguru Yamamoto, Yoshitaka Ogata, et al.. (2014). Ambulatory pulse oximetry monitoring in Japanese COPD outpatients not receiving oxygen therapy. Multidisciplinary Respiratory Medicine. 9(1). 24–24. 5 indexed citations
16.
Minami, Seigo, Masanari Hamaguchi, Suguru Yamamoto, et al.. (2014). Small-cell lung cancer: a case report on the manifestation of paraneoplastic motor neuron disease after effective tumor shrinkage during chemotherapy. International Cancer Conference Journal. 3(4). 247–251. 1 indexed citations
17.
18.
Minami, Seigo, Suguru Yamamoto, Yoshitaka Ogata, et al.. (2013). Emergency department visits after hours by lung cancer patients in Japan. Supportive Care in Cancer. 21(9). 2443–2451. 7 indexed citations
19.
Minami, Seigo, Takashi Kijima, Ryo Takahashi, et al.. (2012). Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study. BMC Cancer. 12(1). 296–296. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephan Spahn Breakdown of academic impact, for papers by Kimberly Tang Breakdown of academic impact, for papers by Dimitrios Korentzelos Breakdown of academic impact, for papers by Nicholas Venturini Breakdown of academic impact, for papers by Daphne N. Pariser Breakdown of academic impact, for papers by Elisabetta Casalone Breakdown of academic impact, for papers by Yasuhide Takeuchi Breakdown of academic impact, for papers by Marcelo Luiz Balancin Breakdown of academic impact, for papers by Marc Cucurull Breakdown of academic impact, for papers by Diane Evrard
Rankless by CCL
2026